{
    "SPADE_UN_28802": {
        "Sequence Information": {
            "Peptide Name": "Cathelicidin-6, BMAP-27(1-18), Myeloid antibacterial peptide 27(1-18)",
            "Sequence": "GRFKRFRKKFKKLFKKLS",
            "Sequence Length": 18,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P54228",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P54228",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                },
                {
                    "uniprotId": "B9UKM3",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/B9UKM3",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                },
                {
                    "uniprotId": "B9UKM4",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/B9UKM4",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                },
                {
                    "uniprotId": "B9UKM7",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/B9UKM7",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                },
                {
                    "uniprotId": "B9UKM8",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/B9UKM8",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                },
                {
                    "uniprotId": "L8HMY4",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/L8HMY4",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.",
                    "Pubmed ID": "8910461",
                    "Reference": "J Biol Chem. 1996;271:28375-28381",
                    "Author": "Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/8910461"
                },
                {
                    "Title": "Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs.",
                    "Pubmed ID": "21497177",
                    "Reference": "Peptides. 2011;32:1123-1130",
                    "Author": "Lee EK, Kim YC, Nan YH, Shin SY",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21497177"
                },
                {
                    "Title": "In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs.",
                    "Pubmed ID": "15019203",
                    "Reference": "Peptides. 2003;24:1723-1731",
                    "Author": "Benincasa M, Skerlavaj B, Gennaro R, Pellegrini A, Zanetti M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/15019203"
                },
                {
                    "Title": "Structural analysis and mode of action of BMAP-27, a cathelicidin-derived antimicrobial peptide.",
                    "Pubmed ID": "31226350",
                    "Reference": "Peptides. 2019;118:170106",
                    "Author": "Yang S, Lee CW, Kim HJ, Jung HH, Kim JI, Shin SY, Shin SH",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31226350"
                },
                {
                    "Title": "Covalent Grafting of Titanium With a Cathelicidin Peptide Produces an Osteoblast Compatible Surface With Antistaphylococcal Activity.",
                    "Pubmed ID": "31644974",
                    "Reference": "Colloids Surf B Biointerfaces. 2019;185:110586",
                    "Author": "Boix-Lemonche G, Guillem-Marti J, D'Este F, Manero JM, Skerlavaj B",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31644974"
                }
            ],
            "Mass": 2342.92,
            "PI": 12.0,
            "Net Charge": 10,
            "Hydrophobicity": -1.29,
            "Frequent Amino Acids": "KFR",
            "Absent Amino Acids": "ACDEHIMNOPQTUVWY",
            "Basic Residues": 10,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 6,
            "Polar Residues": 12,
            "Positive Residues": 10,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_28802",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02465",
                    "Similarity": 1.0,
                    "Sequence": "GRFKRFRKKFKKLFKKLSPVIPLLHLG"
                },
                {
                    "SPADE_ID": "SPADE_N_05877",
                    "Similarity": 1.0,
                    "Sequence": "GRFKRFRKKFKKLFKKLSPVIPLLHL"
                },
                {
                    "SPADE_ID": "SPADE_N_12837",
                    "Similarity": 1.0,
                    "Sequence": "GGGGRFKRFRKKFKKLFKKLSPVIPLLHLG"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:10% Hemolysis=400< µM,Human erythrocytes:50% Hemolysis=>200 µM",
            "Target Organism": "Escherichia coli ATCC 25922(MIC=2µM),Escherichia coli ML-35(MIC=4µM),Escherichia coli D21(MIC=4µM),Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028(MIC=4µM),Serratia marcescens ATCC 8100(MIC=2µM),Staphylococcus aureus ATCC 25923(MIC=2µM),Staphylococcus aureus Cowan 1(MIC=2µM),Staphylococcus aureus(MIC=4µM),Staphylococcus epidermidis ATCC 12228(MIC=1µM),Bacillus megaterium Bm11(MIC=2µM),Candida albicans(MIC=16µM),Cryptococcus neoformans(MIC=4µM),Escherichia coli KCTC 1682(MIC=4µM),Pseudomonas aeruginosa KCTC 1637(MIC=4µM),Salmonella typhimurium KCTC 1926(MIC=2µM),Bacillus subtilis KCTC 3068(MIC=4µM),Staphylococcus epidermidis KCTC 1917(MIC=4µM),Staphylococcus aureus KCTC 1621(MIC=4µM),Enterococcus faecium(MIC=8–>32µM),Streptococcus agalactiae(MIC=1–4µM),Serratia marcescens(MIC=4–>32µM),Escherichia coli O18:K1:H7 Bort(MIC=8µM),Staphylococcus aureus(MIC=4–8µM),Staphylococcus aureus KCTC 1621(MIC=2-4µM),Escherichia coli KCTC 1682(MIC=2-4µM),Human breast adenocarcinoma MDA-MB-361(50-60% Cytotoxicity=>100µM),Human lung carcinoma A549(50-60% Cytotoxicity=>100µM),Staphylococcus epidermidis ATCC 35984(MIC=2µM),Staphylococcus aureus ATCC 25923(MIC=4µM),Pseudomonas aeruginosa ATCC 27853(MIC=2µM)"
        }
    }
}